Standardized recording of product provenance in future clinical trials, through a structured reporting checklist, would help close the first gap, and confirmation of administered dose, such as biochemical verification of intake or electronic dose-monitoring devices, would help address the second.
Shuang Lu, Xin Liu, L. Truong et al.· Journal of clinical pharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.